Search research articles
Contact Us
Filters
Showing results (31-40 of 120) with videos related to
Page
of 12
Sort By:
World Journal of Urology
|
May 7, 2014
Androgen receptor (AR) inhibitor ErbB3-binding protein-1 (Ebp1) is not targeted by the newly identified AR controlling signaling axis heat-shock protein HSP27 and microRNA miR-1 in prostate cancer cells
Matthias B Stope, Stefanie Peters, Hannah Großebrummel, et al.
Cancers
|
November 13, 2025
Non-Invasive Physical Plasma as an Oncological Therapy Option: Modulation of Cancer Cell Growth, Motility, and Metabolism Without Induction of Cancer Resistance Factors
Yanqing Wang, Benedikt Eggers, Alexander Abazid, et al.
Antioxidants (Basel, Switzerland)
|
April 23, 2020
Gas Plasma-Treated Prostate Cancer Cells Augment Myeloid Cell Activity and Cytotoxicity
Sander Bekeschus, Verena Ressel, Eric Freund, et al.
In Vivo (Athens, Greece)
|
December 28, 2018
Overexpression of MicroRNA-1 in Prostate Cancer Cells Modulates the Blood Vessel System of an <i>In Vivo</i> Hen's Egg Test-Chorioallantoic Membrane Model
Arik Reuter, Axel Sckell, Lars-Ove Brandenburg, et al.
Anticancer Research
|
December 1, 2022
Evaluation of the Diagnostic Potential of Circulating MicroRNAs <i>miR-1</i> and <i>miR-21</i> in Patients With Ovarian Cancer
Damian J Ralser, Mateja Condic, Eva Egger, et al.
Journal of Neuroimmunology
|
October 12, 2016
Lack of Toll-like receptor 2 results in higher mortality of bacterial meningitis by impaired host resistance
Martin Böhland, Eugenia Kress, Matthias B Stope, et al.
Anticancer Research
|
June 26, 2024
Modulation of the Prostate Cancer Resistance Factor Hsp27 by the Chemotherapeutic Drugs Abiraterone, Cabazitaxel, Docetaxel and Enzalutamide
Jennifer H S Küster, Holger H H Erb, Hannes Ahrend, et al.
International Journal of Molecular Sciences
|
September 20, 2017
Cold Atmospheric Plasma in the Treatment of Osteosarcoma
Denis Gümbel, Sander Bekeschus, Nadine Gelbrich, et al.
Archives of Gynecology and Obstetrics
|
September 18, 2016
The future therapy of endometrial cancer: microRNA's functionality, capability, and putative clinical application
Matthias B Stope, Dominique Koensgen, Jörg Weimer, et al.
Journal of Cancer Research and Clinical Oncology
|
September 23, 2022
Metabolic changes during prostate cancer development and progression
Alicia-Marie K Beier, Martin Puhr, Matthias B Stope, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 120) with videos related to
Sort By:
Page
of 12
World Journal of Urology
|
May 7, 2014
Androgen receptor (AR) inhibitor ErbB3-binding protein-1 (Ebp1) is not targeted by the newly identified AR controlling signaling axis heat-shock protein HSP27 and microRNA miR-1 in prostate cancer cells
Matthias B Stope, Stefanie Peters, Hannah Großebrummel, et al.
Cancers
|
November 13, 2025
Non-Invasive Physical Plasma as an Oncological Therapy Option: Modulation of Cancer Cell Growth, Motility, and Metabolism Without Induction of Cancer Resistance Factors
Yanqing Wang, Benedikt Eggers, Alexander Abazid, et al.
Antioxidants (Basel, Switzerland)
|
April 23, 2020
Gas Plasma-Treated Prostate Cancer Cells Augment Myeloid Cell Activity and Cytotoxicity
Sander Bekeschus, Verena Ressel, Eric Freund, et al.
In Vivo (Athens, Greece)
|
December 28, 2018
Overexpression of MicroRNA-1 in Prostate Cancer Cells Modulates the Blood Vessel System of an <i>In Vivo</i> Hen's Egg Test-Chorioallantoic Membrane Model
Arik Reuter, Axel Sckell, Lars-Ove Brandenburg, et al.
Anticancer Research
|
December 1, 2022
Evaluation of the Diagnostic Potential of Circulating MicroRNAs <i>miR-1</i> and <i>miR-21</i> in Patients With Ovarian Cancer
Damian J Ralser, Mateja Condic, Eva Egger, et al.
Journal of Neuroimmunology
|
October 12, 2016
Lack of Toll-like receptor 2 results in higher mortality of bacterial meningitis by impaired host resistance
Martin Böhland, Eugenia Kress, Matthias B Stope, et al.
Anticancer Research
|
June 26, 2024
Modulation of the Prostate Cancer Resistance Factor Hsp27 by the Chemotherapeutic Drugs Abiraterone, Cabazitaxel, Docetaxel and Enzalutamide
Jennifer H S Küster, Holger H H Erb, Hannes Ahrend, et al.
International Journal of Molecular Sciences
|
September 20, 2017
Cold Atmospheric Plasma in the Treatment of Osteosarcoma
Denis Gümbel, Sander Bekeschus, Nadine Gelbrich, et al.
Archives of Gynecology and Obstetrics
|
September 18, 2016
The future therapy of endometrial cancer: microRNA's functionality, capability, and putative clinical application
Matthias B Stope, Dominique Koensgen, Jörg Weimer, et al.
Journal of Cancer Research and Clinical Oncology
|
September 23, 2022
Metabolic changes during prostate cancer development and progression
Alicia-Marie K Beier, Martin Puhr, Matthias B Stope, et al.
Page
of 12